PC3I News
The University of Pennsylvania (Penn) Telehealth Research Center of Excellence (Penn TRACE), based at the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center, is one of four National Cancer Institute (NCI) Telehealth Research Centers of Excellence dedicated to advancing the nation’s telehealth research agenda focused on improving cancer-related care and outcomes. With support from the White House Cancer Moonshot, Penn TRACE applies insights from communication science and behavioral economics to design and test innovative telehealth approaches to improve effectiveness and equity across the cancer care continuum, with an emphasis on advancing health equity and addressing the digital divide.
Three PC3I Innovation Faculty will lead the center as principal investigators: Katharine Rendle, PhD, MSW, MPH; Anil Vachani, MD, MS; and Justin Bekelman, MD, Director of PC3I.
Read the full Penn Medicine press release as well as the National Cancer Institute press release.
Learn more about Penn TRACE.
Related News
PC3I News
PC3I Fellow Timothy Brown Receives ASCO Award for Liver Cancer Research
01.18.2023
For a novel investigation into a common and deadly form of liver cancer, PC3I Innovation Fellow Timothy Brown, MD, recently received an ASCO Conquer Cancer Merit Award.
PC3I News
PC3I Fellow Recognized for Research on Breast Cancer Disparities in Black Patients
12.22.2022
For her work leading innovative research into racial disparities in breast cancer care, Sara Ginzberg, MD, recently received a Clinical Scholar Award from the San Antonio Breast Cancer Symposium.
PC3I News
PC3I at ASH Annual Meeting and Exposition 2022
12.09.2022
Four Penn Center for Cancer Care Innovation (PC3I) Faculty will be presenting the latest advances in blood cancer research and treatment at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition.